Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012 (2012), Article ID 417673, 8 pages
http://dx.doi.org/10.1155/2012/417673
Research Article

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

1Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium
2Medical Oncology, Galliera Hospital, Via Volta 6, 16125 Genoa, Italy

Received 4 May 2012; Accepted 1 August 2012

Academic Editor: Maryam Lustberg

Copyright © 2012 José R. Rossari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

José R. Rossari, Otto Metzger-Filho, Marianne Paesmans, et al., “Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence,” Journal of Oncology, vol. 2012, Article ID 417673, 8 pages, 2012. doi:10.1155/2012/417673